Aperture Venture Partners V Overview

  • Fund Type
  • Venture

  • Fund Status
  • Closed

  • Vintage
  • 2019

Vintage

  • Dry Powder

Aperture Venture Partners V General Information

Description

Aperture Venture Partners V is a venture capital fund managed by Aperture Venture Partners. The fund is located in New York, New York.

Contact Information

Fund Manager Website
Fund Category
Venture Capital
Former Name
Aperture Ventures V
Open Date
Close Date
Fund Family
Aperture Venture Partners
Native Currency
USD
Fund Manager's Location
  • 645 Madison Avenue
  • 20th Floor
  • New York, NY 10022
  • United States
+1 (212)
Fund Domiciles
United States: Delaware

Aperture Venture Partners V Investments (8)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cortica (Clinics/Outpatient Services) 29-Jun-2021 Clinics/Outpatient Services Generating Revenue
Neuros (Healthcare Technology Systems) 07-Jan-2021 Therapeutic Devices Generating Revenue
Cardiac Dimensions 28-Sep-2020 Therapeutic Devices Generating Revenue
DeVoro Medical 02-Jul-2020 Surgical Devices Generating Revenue
Tarsus Pharmaceuticals 08-Jan-2020 Drug Discovery Clinical Trials - Phase 3
Verix Health 22-Oct-2019 Surgical Devices Generating Revenue
Endotronix 24-Sep-2019 Later Stage VC (Series D) Enterprise Systems (Healthcare) Generating Revenue
Bardy Diagnostics 16-Apr-2019 Later Stage VC (Series B) Monitoring Equipment Generating Revenue
To view Aperture Venture Partners V’s complete investments history, request access »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aperture Venture Partners V Investment Strategy

Investments by Industry

Investments by Deal Type

PitchBook helps you see a fund’s investments based on target industry, year and deal type—so you can quickly understand its strategy at a glance.

Request a free trial

Aperture Venture Partners V Team (1)

Name Title Deals Funds Boards Office
Anthony Natale MD Managing Partner New York, NY
To view Aperture Venture Partners V’s complete team members history, request access »

Aperture Venture Partners V Returns Data

The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.

IRR (%)

 

DPI (x)

 

RVPI (x)

 

TVPI (x)

 

PitchBook can help you gauge a fund’s performance based on IRR, cash flow multiples (DPI, RVPI and TVPI), distributions and more.

Request a free trial

Aperture Venture Partners V FAQs

  • What is Aperture Venture Partners V?

    Aperture Venture Partners V is a venture capital fund managed by Aperture Venture Partners.

  • Who manages Aperture Venture Partners V?

    Aperture Venture Partners V is managed by Aperture Venture Partners.

  • Where is Aperture Venture Partners V domiciled?

    Aperture Venture Partners V is domiciled in United States: Delaware.

  • What type of fund is Aperture Venture Partners V?

    The fund type of Aperture Venture Partners V is Venture.

  • What is the status of Aperture Venture Partners V?

    Aperture Venture Partners V is closed.

  • What has Aperture Venture Partners V invested in?

    Aperture Venture Partners V has made numerous investments in companies like Cortica (Clinics/Outpatient Services), Neuros (Healthcare Technology Systems), and Cardiac Dimensions within the Clinics/Outpatient Services and Therapeutic Devices industries.

  • What has Aperture Venture Partners V invested in recently?

    Aperture Venture Partners V's latest investment was on 29-Jun-2021 in Cortica (Clinics/Outpatient Services), a company within the Clinics/Outpatient Services industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »